Searching for a cure, Improving lives

Allocation of funding and process


Action Duchenne implemented some research policy documentation in 2010, which outlines terms of reference and procedures. These policies still stand, but the implementation has been slightly modified to reflect the changing research world and needs from the community.


Action Duchenne launched the biannual call for applications at last year’s international conference. This means that applications will only be considered in January and July and will take at least three months to be evaluated in the peer-review process.

We invite any international researcher/academic or indeed clinician to submit either a pre-application or full application form directly to Diana Ribeiro, Head of Research, Action Duchenne:  If the application fits our research strategy, the applicant will be informed and during the funding cycle enter into the peer-review process.


AD_Pre-application Form


Final AD application form (for applicants)


Action Duchenne Scientific Advisory Board Terms of Reference


Action Duchenne Peer Reviewing Policy


Action Duchenne have implemented a two stage peer-review process (see Figure 5). Only if the application passes both peer-review rounds will the project be fully or partially funded.

The aim of this process is to select the best proposals based on the advice and expertise of our lay and scientific advisory board, which are independent and provide both vital perspectives in reaching the funding decision. Our scientific advisory board, international and leading experts in Duchenne research offer the best possible support and rigour behind this process.

Furthermore, as well as the standards of review criteria we established in 2010. Action Duchenne has adopted the NIH scoring system; this was designed to encourage reliable scoring of applications.


Figure 5 Schematic diagram depicting Action Duchenne’s peer-review process and allocating grants

Figure 5 Schematic diagram depicting Action Duchenne’s peer-review process and allocating grants


Grant monitoring

Once a contract is placed, Action Duchenne leads the way in monitoring these grants. Principal investigators leading the proposal are required to submit quarterly reports or updates around significant project milestones. This is assessed and compared to the original project aims. After a project is complete Action Duchenne will share the main findings (non-confidential data) and encourage these key figures to present at our annual international conference and engage with our supporters and delegates.




Support Action Duchenne with a monthly or one off donation



View our events

View All Events


Join the DMD registry for access to clinical trials


Action Duchenne launches new Research Strategy for Duchenne muscular dystrophy

November 17th, 2017

  Action Duchenne, a leading UK-wide patient and parent-led organisation for Duchenne Muscular Dystrophy, is

Tell me more

Long-term microdystrophin pre-clinical work, moving towards a potential therapy restores muscle function in canines

July 26th, 2017

Promising microdystrophin pre-clinical work, moving towards a potential therapy has shown to restore muscle function

Tell me more

FDA new approach would reduce number of patients treated with placebo

December 11th, 2017

The U.S. Food and Drug Administration (FDA) has published its recommendation for a new approach

Tell me more

Results announced from survey ‘Juggling care and daily life’

December 11th, 2017

The 17th October 2017 was an important date for the rare disease community.  The highlights of the

Tell me more

Duchenne – How do you measure a life?

Living with Duchenne – an animation

Taking charge of Duchenne

wordpress counter

Stay informed with regular updates from Action Duchenne